BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1342702)

  • 1. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():1-9. PubMed ID: 1342702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Trop Geogr Med; 1994; 46(4 Spec No):242-6. PubMed ID: 7825228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a vaccine strategy against human and bovine schistosomiasis. Background and update.
    Capron A; Riveau G; Grzych JM; Boulanger D; Capron M; Pierce R
    Mem Inst Oswaldo Cruz; 1995; 90(2):235-40. PubMed ID: 8531664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic aspects of schistosomiasis.
    Capron A; Dessaint JP
    Annu Rev Med; 1992; 43():209-18. PubMed ID: 1580585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies against schistosomiasis.
    Capron A; Dessaint JP; Capron M; Pierce RJ
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():19-27. PubMed ID: 1343894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine strategies against schistosomiasis: from concepts to clinical trials.
    Capron A; Capron M; Dombrowicz D; Riveau G
    Int Arch Allergy Immunol; 2001; 124(1-3):9-15. PubMed ID: 11306914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity induced in rat schistosomiasis by a single dose of the Sm28GST recombinant antigen: effector mechanisms involving IgE and IgA antibodies.
    Grezel D; Capron M; Grzych JM; Fontaine J; Lecocq JP; Capron A
    Eur J Immunol; 1993 Feb; 23(2):454-60. PubMed ID: 8436179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
    Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
    PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector functions of eosinophils in schistosomiasis.
    Capron M; Capron A
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():167-70. PubMed ID: 1343889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to schistosomes: progress toward vaccine.
    Capron A; Dessaint JP; Capron M; Ouma JH; Butterworth AE
    Science; 1987 Nov; 238(4830):1065-72. PubMed ID: 3317823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parasite glycans and antibody-mediated immune responses in Schistosoma infection.
    van Diepen A; Van der Velden NS; Smit CH; Meevissen MH; Hokke CH
    Parasitology; 2012 Aug; 139(9):1219-30. PubMed ID: 22423613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
    El Ridi R; Tallima H
    Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for a schistosome vaccine.
    Capron A; Riveau GJ; Bartley PB; McManus DP
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Oct; 2(3):281-90. PubMed ID: 12476492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA antibodies to a protective antigen in human Schistosomiasis mansoni.
    Grzych JM; Grezel D; Xu CB; Neyrinck JL; Capron M; Ouma JH; Butterworth AE; Capron A
    J Immunol; 1993 Jan; 150(2):527-35. PubMed ID: 8419485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma mansoni tegument protein Sm29 is able to induce a Th1-type of immune response and protection against parasite infection.
    Cardoso FC; Macedo GC; Gava E; Kitten GT; Mati VL; de Melo AL; Caliari MV; Almeida GT; Venancio TM; Verjovski-Almeida S; Oliveira SC
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e308. PubMed ID: 18827884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the immune response to DNA vaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon.
    Siddiqui AA; Pinkston JR; Quinlin ML; Saeed Q; White GL; Shearer MH; Kennedy RC
    Vaccine; 2005 Feb; 23(12):1451-6. PubMed ID: 15670880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
    Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
    Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific humoral response of hosts with variable schistosomiasis susceptibility.
    Driguez P; McWilliam HE; Gaze S; Piedrafita D; Pearson MS; Nakajima R; Duke M; Trieu A; Doolan DL; Cardoso FC; Jasinskas A; Gobert GN; Felgner PL; Loukas A; Meeusen E; McManus DP
    Immunol Cell Biol; 2016 Jan; 94(1):52-65. PubMed ID: 26044065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosomiasis vaccines: Farewell to the God of Plague?
    Taylor MG
    J Trop Med Hyg; 1994 Oct; 97(5):257-68. PubMed ID: 7932921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.